Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
about
Ubiquitylation of autophagy receptor Optineurin by HACE1 activates selective autophagy for tumor suppressionLong noncoding RNAs in cancer: mechanisms of action and technological advancementsMicroRNA biogenesis pathways in cancerGenetic and nongenetic risk factors for childhood cancerCASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.Lin28: primal regulator of growth and metabolism in stem cellsLin28 sustains early renal progenitors and induces Wilms tumorOverview and recent advances in the treatment of neuroblastoma.Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction.11q deletion in neuroblastoma: a review of biological and clinical implications.HSD17B12 gene rs11037575 C>T polymorphism confers neuroblastoma susceptibility in a Southern Chinese populationIntegrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsA genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinomaGenetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.Multiple mechanisms disrupt the let-7 microRNA family in neuroblastomaExpression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma.Polymorphisms in the calcium-sensing receptor gene are associated with clinical outcome of neuroblastoma.Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma.Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans.Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma.Neuroblastoma: developmental biology, cancer genomics and immunotherapy.Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addictionGenome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans.The role of intracellular calcium for the development and treatment of neuroblastoma.Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications.CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility LocusA Single Let-7 MicroRNA Bypasses LIN28-Mediated Repression.Childhood cancer: an emerging public health issue in China.Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma.The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population.The genetic landscape of high-risk neuroblastoma.Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibilityPotentially functional polymorphisms in the LIN28B gene contribute to neuroblastoma susceptibility in Chinese children.Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese populationNeuroblastoma and MYCNLMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7
P2860
Q24300797-C43B977D-4569-4B86-86AD-E4030802D93BQ26745528-72B3CF54-1CAB-4EA3-A881-124714D7E285Q27013841-D18551A9-0F1A-4EB2-BDF1-8C7A3389B693Q27693894-33A432C2-DCC9-4705-A078-9C70279870E8Q27853102-E9EC5685-96E6-4E66-A972-95955FACFB86Q28288454-71C7F79E-E14E-4C96-886D-92ED98370D84Q28511047-AFB2FFEF-13C0-4C72-9289-40F9BDC29E97Q30238693-5F36CC92-9C7D-4365-BD48-89DB53F9531CQ30239861-5757DA36-F627-4043-A38B-B303CE9202D4Q30253080-C1DDEA49-634A-4D64-B9B3-82A07E38E5B5Q30536922-1D22FD90-28D5-46C3-8ED8-1E1C2722F897Q32174267-E0C73BB4-9849-4574-B1DE-4C3B2394DA7DQ33553664-2105D0E4-3343-4D22-BA97-45DE274B7BBDQ33645629-FD2848D9-F435-4B2C-A801-95C1A944B965Q33858532-71FB2D20-9BF2-4939-9C55-E3C6215B0C08Q34501408-5A51C3C5-6D13-4E30-AD70-B5360E6843BDQ34533112-E10C0E4B-1D15-4B02-A78C-309278B8579AQ34609220-62854943-5C5D-4D33-81EC-CCE29753CF98Q34637949-36F252C3-7164-4084-A01A-7069B5DDA3A5Q35034812-B0483BED-6856-4A6F-94F9-B81020ECCBCEQ35044246-67598AEE-F76E-4221-B313-9A2D11FD4171Q35238424-019E8E2A-B0A3-4B28-940E-D3937D1F597EQ35283020-CEE146C0-8572-43B4-AC0B-B72B9F9E8193Q35287869-4420C990-DBD4-4EFC-8B43-D57CD91A328BQ35565624-90C9F4DD-310D-4757-B1A0-CA1F334D2C0AQ35635465-F6FD6397-F1B9-4E43-8866-BC1738B5B8C8Q35818437-83920ECD-AFFB-4B52-9F7C-BDF004CA0CC7Q35818443-ED7CE06C-F1A2-46A5-91D8-4DD50D506709Q35920704-71A2DFA8-6D78-45E0-B395-6154EC58FC7BQ36167234-E3B4C573-F174-4418-80CD-0A13F44CD84BQ36204952-7C442EBD-25DC-4935-8442-A2693EE06A10Q36381614-C2EA5EE9-153A-4E66-977C-F60BDDD99A4DQ36610631-760E6AD8-9F43-43AC-B29D-29FEA73CB353Q36929803-E3F8D80D-484F-4380-A9A1-AB4EEC990942Q37026820-5EF7CFEE-5FFA-439C-9696-5ED7AA4907E4Q37117136-1688E8A1-48EE-4C91-B144-6FD5B69442D7Q37117165-E077A130-D337-40E6-A6D0-ADAA0D6C76C1Q37201479-7F830A2F-7FA8-4988-ABD7-DC874A8703A6Q37225669-B7BDFAE2-8ACE-4B59-9105-321C28D7B044Q37271808-D8A8A9E7-DBE9-4CD7-9A1A-430368883474
P2860
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
description
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
articolo scientifico
@it
artículu científicu espublizáu en 2012
@ast
im Oktober 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2012/10/01)
@nl
наукова стаття, опублікована в жовтні 2012
@uk
مقالة علمية (نشرت في أكتوبر 2012)
@ar
name
Common variation at 6q16 withi ...... usceptibility to neuroblastoma
@ast
Common variation at 6q16 withi ...... usceptibility to neuroblastoma
@en
type
label
Common variation at 6q16 withi ...... usceptibility to neuroblastoma
@ast
Common variation at 6q16 withi ...... usceptibility to neuroblastoma
@en
prefLabel
Common variation at 6q16 withi ...... usceptibility to neuroblastoma
@ast
Common variation at 6q16 withi ...... usceptibility to neuroblastoma
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Common variation at 6q16 withi ...... usceptibility to neuroblastoma
@en
P2093
Achille Iolascon
Cuiping Hou
Cynthia Winter
Edward F. Attiyeh
Erica L. Carpenter
Jayanti Jagannathan
John M. Maris
Kristina A. Cole
Maura Diamond
P2860
P2888
P304
P3181
P356
10.1038/NG.2387
P407
P577
2012-10-01T00:00:00Z
P5875
P6179
1046277408